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Accumulating evidence from animal models and human studies of essential hypertension suggest that brain regulation of the
vasculature is impacted by the disease. Human neuroimaging findings suggest that the brain may be an early target of the disease.
This observation reinforces earlier research suggesting that psychological factors may be one of the many contributory factors to
the initiation of the disease. Alternatively or in addition, initial blood pressure increases may impact cognitive and/or affective
function. Evidence for an impact of blood pressure on the perception and experience of affect is reviewed vis-a-vis brain imaging
findings suggesting that such involvement in hypertensive individuals is likely.
1. Introduction
Despite a long history of putative relationship between essen-
tial hypertension and psychological function, clear, partic-
ularly mechanistic, relationships remain elusive. Early work
in humans postulated relationships between anger regulation
and blood pressure [1] and work in animal models has long
shown brain involvement in heightening blood pressure [2–
4]. Recent animal investigations have reinforced this relation-
ship and further implicated immune influences on blood
pressure control [5]. The advent of brain imaging has been
useful in specifying more clearly the neural involvement in
hypertension and providing a possible bridge between be-
havioral and self-report information in humans and the
mechanistic observations in animal models. The initial focus
of the current paper is on neuroimaging results in humans.
We argue that these findings suggest that the brain is an early
target for hypertension. We then explore the implications
for cognition and affect of these brain findings. Ideally,
brain imaging can be used to further not only assessment
of brain mechanisms but also complement psychological
and neurophysiological investigations of the widely prevalent
disease of essential hypertension.
2. Cross-Sectional Findings
Our work has led us to raise the possibility that essential
hypertension early in its course alters brain function, see
recent summary [6]. Initial studies compared normotensive
individuals with hypertensive individuals without recent
history of medication treatment [7, 8]. Based on prior work
showing mild cognitive deficits in hypertensive individuals
[9], we examined brain function using positron emission
tomography while participants performed a working mem-
ory task; brain structure was assessed using magnetic res-
onance imaging. Similarities of performance and brain func-
tion were more striking than differences between the two
groups, but a number of differences were evident. During
memory performance, normotensive participants showed a
greater regional cerebral blood flow (rCBF) response in the
posterior parietal and thalamic brain areas, while hyperten-
sive participants showed a greater extent of activation in the
prefrontal cortex [10]. Relatedly, the activation of different
areas of the brain during the memory task was more
highly correlated in hypertensive relative to normotensive
participants [8]. Other investigators have reported relatively
decreased grey matter volume in certain brain areas among
hypertensive relative to normotensive individuals [11, 12],
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and we found differences as well [13]. Similarly, our results
were consistent with prior reports of brain indices of aging.
Namely, decreases in ventricular volumes in the brain as well
as increases in prevalence of white matter hyperintensities
were more evident in hypertensive individuals compared to
similarly aged normotensive individuals, for example, [14].
Finally, blood pressure reactivity to laboratory challenges
is known to prospectively relate to essential hypertension
[15], and work of our colleague, Peter Gianaros, has shown
consistent relationships between degree of activation in a
number of limbic brain regions and degree of blood pressure
response to challenges [16–19]. The results of our cross-
sectional work clearly established that the human brain was
impacted by hypertension. The presence of brain correlates
of blood pressure responding in normotensive individuals
suggested that blood pressure reactivity might be contribut-
ing to the later impact of hypertension on the brain. These
results lead us to propose a vascular hypothesis suggesting
that vascular responses as well as chronic cerebrovascular
changes due to the disease had a subsequent impact on neural
and thus neuropsychological (cognitive) function [7].
3. Longitudinal Findings
An intervention study based on our cerebrovascular hypoth-
esis, however, led us to consider an alternative possibility
that neural changes preceded or were concomitant with
vascular changes induced by essential hypertension. Based on
our vascular hypothesis, we treated previously unmedicated
hypertensive patients for a year with an angiotensin convert-
ing enzyme (ACE) inhibitor or with a beta blocker. Prior
work suggested that the ACE inhibitor would reverse vascular
morphology changes associated with hypertension while the
beta blocker would not, for example, [20, 21]. Remediation
of the vascularmorphology was then expected to enhance the
capability of the hypertensive patients to vasodilate cortical
vessels and hence more effectively adjust blood flow to active
brain areas. In fact, despite excellent reductions in blood
pressure by both medications, no differences between them
or in pre- to postassessments occurred in resting or task-
related cerebral blood flow [22]. Despite this failure of the
test of our vascular hypothesis, some important observations
were made. We had expected the lowering of blood pressure
to reverse or stabilize brain indices that we had related to
hypertension in our cross-sectional study. In fact, the degree
of concomitant activation across brain areas increased and
grey matter volume loss continued [23, 24]. Moreover, the
degree of brain aging pretreatment and the robustness of the
thalamic response to working memory pretreatment were
predictive of the success of blood pressure lowering [22].
The state of the brain seemed to be a proxy for the severity
of the essential hypertension. In short, a pathophysiological
process underlying essential hypertension seemed to be
continuing to influence the brain—peripheral pressure per se
did not seem to be causing the brain changes that continued
to be observed. Arguably, our intervention was only a
year in the course of a long-lasting disease and alternative
interpretations can be drawn. At present, we are attempting
to support the hypothesis that brain changes are an early
target of hypertension by examining whether brain signs of
essential hypertension are present prior to or concurrently
with the changes in blood pressure that lead to diagnosed
essential hypertension.
4. Pathophysiology of Essential Hypertension
What are the implications of the possibility that essential
hypertension is a disease that influences the brain early
in its course? Furthermore, what factors might predispose
individuals to essential hypertension and be so prevalent in
our society that more than half of us over the age of sixty
have essential hypertension? One implication is that factors
influencing the brain rather directly, such as psychosocial
factors, may be as important as biological and behavioral
factors in contributing to the etiology of essential hyperten-
sion. This implication is hardly novel; it has been posited for
many years, particularly within the psychosomatic medicine
tradition. Few, however, believe that psychosocial factors
are the sole cause of essential hypertension. The best
concept of the causation of hypertension may still be the
mosaic theory of Page [25, 26] that emphasizes the multiple
factors known to influence the disease and the regulatory
interactions between these factors. Essential hypertension is
then expected to arise from not a single factor but rather
numerous and likely different combinations of factors. Any
particular combination of dysregulated processes may then
overwhelm the complex, but redundant regulatory system
that aims to maintain normal blood pressure. Approximately
30 years ago, Weiner [27] provided a comprehensive review
of the psychobiology of hypertension with careful attention
to extant work in humans and animal models. His approach
echoed the mosaic theory, but evidence was updated and
viewed from a psychosomatic perspective. The general
conclusions from that review remain valid today. Essential
hypertension appears to have multiple causes and may not
even be a single disease. In addition, the factors inducing high
blood pressure may not be the same as those maintaining
the high blood pressure. The various etiological possibilities
all involve a failure of regulatory function—within neural
control of blood pressure, renal, and/or endocrine function.
Recent work has largely reinforced these conclusions [30–
33]. Factors in the pathophysiology of hypertension noted
by Page remain important and our knowledge of these
individually are growing, for example, genetic, endocrine,
and immune factors [5, 34–38]. Of note, greater attention
to renal involvement in hypertension has been combined
with greater knowledge of the interaction of renal and neural
control [39–43].
We can examine the renin-angiotensin system more
closely to illustrate the increasing importance of central regu-
lation. The peripheral renin-angiotensin system has well-
known influences on the kidney and vasculature, but main-
tenance of blood pressure also seems to involve renin-angi-
otensin present in the central nervous system. Angiotensin is
present and appears active in the nucleus tractus solitarius
and the dorsolateral ventral medulla—important blood
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pressure regulatory areas [44]. Circulating angiotensin is
also known to influence the brain via transmission through
the circumventricular organ. Brain angiotensin influences
neuroendocrine systems and, more surprisingly, influences
learning and memory in animal models [45, 46]. Finally,
angiotensin is responsive to stress and antagonists appear
to both lessen stress responses and improve learning and
memory in animal models [45, 46]. Thus, a disruption of the
renin-angiotensin system would concurrently impact both
brain and vascular function. This may account in part for
interest in medication influencing brain angiotensin recep-
tors that preserves brain function while reducing peripheral
blood pressure as well as other medication [47].
5. Central Factors in Essential Hypertension
As part of the mosaic of disease factors, the involvement of
neural control in affected regulatory systems suggests that
the nervous system is contributory to the etiology and main-
tenance of some, if not all forms of, essential hypertension
as well as it being a target of the disease. In reviewing
the then-popular concept of “borderline hypertension,”
Weiner found stress to be a supportable factor influencing
the pathophysiology of essential hypertension presumably
through its impact on brain function. He found reasonably
strong evidence for stressful experience moderating the
development of hypertension in animal models, potential
mediation by sympathetic nervous system dysfunction, and
remediation of blood pressure with interventions on neural
control. If anything since Weiner’s review, psychological
factors have been increasingly mentioned among initiating
factors in concepts of hypertension unifying neural and renal
factors in the disease, for example, [48, 49] The number
of mechanisms which could be impacted by neural control
has grown, but linking them to initiating factors is complex,
particularly in humans. How the various influential factors
become dysregulated and interact to create the natural
history of regulatory failures that can lead to hypertension
remains unknown. In short, as our knowledge of blood
pressure regulation expands, the intertwining of neural,
endocrine, and immune control becomes more evident as
does the importance of central nervous system control. The
robustness of these conclusions, however, should not be
construed as resolving the primary question. We lack an
empirically supported, general model of how blood pressure
control is integrated such that essential hypertension occurs
when a dysfunction occurs within one or, more likely, more
contributory mechanisms.
Coordination by the brain does, however, seem critical
to the operation of such a multifaceted control system.
Regulatory failure due to any cause must influence normal
brain function because the brain normally maintains nor-
motensive levels of blood pressure. Brain counterregulation
must fail, the brain itself may be affected, or the range of
regulation possible must simply be exceeded so that the
brain becomes permissive of heightened pressures. From this
perspective, the brain must be an early target of essential
hypertension. It remains arguable whether brain pathology
is a primary initiating factor in essential hypertension.
What psychological/behavioral factors might impact the
brain and contribute to hypertension and be consistent with
the present day pandemic level of essential hypertension?
Diet/salt intake, physical inactivity, and stress seem likely
candidates—factors readily related to demonstrated influ-
ences on hypertension (see, e.g., [50]).
For the remainder of our discussion we will focus on
stress as an important factor that acts in concern with other
biological and psychosocial factors. This focus is partially
one of our personal interests, but one could argue that
diet/salt and physical inactivity are themselves driven in part
by coping with stress. In this context, it is important to
point out that our discussion will proceed from accepting
the global use of the term “stress” for purposes of the
reviewing literature to a more specific examination of
affective processing. In the future, it may be useful to assess
separable influences of the environmental or psychological
stressor, the individual’s appraisal of such stressors, and
their evaluation and use of particular coping strategies, see
Lazarus [51, 52]. For example, the idea that overeating and
physical inactivity are coping activities in response to stress is
typically not well-supported empirically due tomeasurement
difficulties as well as, typically, the investigators’ greater
interest in the maladaptive behavior itself and less with
its exact source. Stress encompassing the constellation of
involved stressors and processes provides a convenient proxy
until we can analytically separate factors most critical for
our dependent variable of interest, be it hypertension or
dysphoria.
A second reason for our focus on stress is another finding
from our treatment study that we briefly reviewed at the
beginning of this paper. Examining individual differences
in both the response to treatment of blood pressure and
working memory performance, we observed a dorsomedial
prefrontal area that was related to both [28]. The result
suggested that activation in this area favored successful
reduction in blood pressure levels but at the cost of poorer
performance on working memory (in comparison to their
pretreatment performance). As shown in Figure 1, in the
same general brain area, we observed significant subareas
in which significant regional cerebral blood flow activation
posttreatment relative to pretreatment: (a) correlated with
how well a participant had lowered blood pressure, (b) cor-
related negatively with the change in memory performance,
and (c) correlated with both blood pressure lowering and
memory performance—an area sharing these correlations. A
thorough quantitative review of the literature [29] suggested
that this virtually exact dorsomedial prefrontal area related
to the contextual factors influencing emotion as well as to
autonomic reactivity. Subsequent work (reviewed through
http://www.neurosynth.org/) continues to support this func-
tional relationship to affective responses to faces and scenes
[53] and to autonomic nervous system responding [54, 55].
The latter paper is particularly relevant in that the dor-
somedial prefrontal cortex showed an overlapping area that
related to both autonomic responding (heart rate variability,
blood pressure was not reported upon) as well as affective
evaluation. Dorsomedial prefrontal cortex activation has
4 International Journal of Hypertension
+42 +44 +46
+48 +50 +52
+54 +56 +58
Figure 1: Dorsomedial prefrontal area in which greater regional
cerebral blood flow post-treatment related to either better blood
pressure decrease (red), poorer post-relative to pretreatment work-
ing memory performance (blue), or both (green). See details and
relevant review [28, 29].
been related to empathetic responses with greater activation
related to less tendency for personal distress [56]; a finding
related to the modulation of dorsomedial prefrontal acti-
vation when anticipatory set was used to modulate affect
[57]. Notably though, some work has shown the dorsomedial
prefrontal cortex to be related to greater cortisol response
to stress [58]; while other work again suggests activation
of this area to be related to lower sensitivity to fear and
disgust [59]. Overall, the literature seems consistent with
an interpretation that at least portions of the dorsomedial
prefrontal area organize affective and autonomic response
to a challenge. If so, we then speculate that successful blood
pressure regulation altered this organization in our treatment
study. After treatment, a damping of the cognitive/affective
response to challenge may have been instrumental in
maintaining lower blood pressure. If this interpretation is
correct, we could suspect that individual differences in the
affective evaluation and response to situations might relate
to the control of blood pressure and that these individual
differences that might be expected to relate to individual
differences in activation of dorsomedial prefrontal cortex.
An alternative to examining affective regulation would be
examining cognitive function vis-a-vis hypertension. Indeed,
our work was launched based on reviews showing that
hypertensive individuals performed slightly more poorly
than normotensive individuals on tests of executive attention
and working memory [9, 60]. Cognitive function, however,
remained stable throughout our treatment study. In addi-
tion, regional cerebral blood flow responses to a working
memory task were unaffected by the successful treatment of
blood pressure.
6. Stress and Hypertension
The notion that stress causes hypertension is popularly
accepted, but the scientific basis for this is somewhat
lacking. An initial issue is simply that stress refers to a
host of conditions so that the statement that stress causes
hypertension is simply impossibly vague. Scientific usage
varies between stress defined as a response to a laboratory
computer challenge or a daily hassle, to stress defined as
the loss of a spouse or as a response to a continuing
divorce proceeding. The popularity of the term likely stems
from the sense that external events rather than one’s own
personality or misbehavior are inducing a negative psycho-
logical reaction. Being stressed is more socially acceptable
than other alternatives for explaining negative psychological
states. Stress, though, is certainly an interaction between
the person and the environmental situation as so elegantly
described by Lazarus [51, 52].
Reviews of stress and hypertension vary somewhat in
how they use the stress concept, but generally are only
minimally supportive of a relationship between stress, var-
iously defined, and hypertension. Nyklicˇek et al. [61] found
that objective measures of stress were related to heightened
blood pressure (though not all studies assessed essential
hypertension per se). Objective measures in this paper
included exposure to natural disasters, unsafe neighborhood
conditions, noise exposure, and stressful occupation. In con-
trast they report minimal association when self reported
stress was related to blood pressure. They make a reasonable
case for a difference between studies examining hypertensive
patients aware of their disorder relative to studies examining
individuals unaware of their blood pressure status. Hyper-
tensive patients were seen as tending to report a stressful
background, possibly as an explanation to themselves of their
condition. Unaware individuals with high blood pressure
were observed to report low levels of stress and overall high
psychological wellbeing. The reviewers suggest that contra-
dictory findings relating hypertension to recalled stressful life
events and occupational stress may be due in part to this
dependence of stress reporting on awareness of hypertension.
Another review examines an individual difference dimension
that was developed specifically in relation to stress and
hypertension in African Americans. As reviewed by Bennett
et al. [62], John Henryism refers to a style of coping with
stress—specifically, continuous active coping—that theoreti-
cally would positively correlate with blood pressure in groups
faced with chronic stress and few resources, that is, lower
class African Americans. Initial evidence supported this con-
ceptualization, but the review notes results suggesting that
the concept is not specific to African Americans and has been
related to blood pressure in some studies regardless of social
class or even more strongly in upper classes. John Henryism
is interesting since that coping style contrasts markedly with
the earlier descriptions of the hypertensive personality (see
below). The concept may align more closely with work stress
in the presence of little job control. Nonetheless, the review
suggests that the relationship of John Henryism to blood
pressure is now more obscure than when the concept was
introduced. A more recent review [63] selected only studies
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that were longitudinal or used case-control designs (reducing
studies examined from 82 to 14, but still with over fifty-
two thousand individuals included). Three studies examined
the hypertensive aftermath of acute stressors, such as natural
disasters, and no association was found between the acute
stressors and blood pressure. This is in contrast to the prior
review and suggests that the shorter term blood pressure
increases after acute stress events may not be sustained, that
is, essential hypertension may not be expressed after 3 years
or more have passed since the acute event. When chronic
stress was reviewed, the seven qualifying studies generally
supported an association with better evidence for job stress.
Affective response was examined and included reports of
hopelessness and racial discrimination, that is, internalized
responses assumed to result from a history of stressful events.
Although mixed, the majority of these studies did show an
association albeit not large between the affective response
and hypertension. Overall, positive odds ratios from their
reviews predominated, but the authors reserved judgment
until better-designed studies with well-defined exposures
and control for confounds were available. It is unfortunate
that this review did not consider the hypertension awareness
issue raised in the Nyklicˇek review.
7. Cardiovascular Reactivity and Stress
One definition of stress of direct relevance to hypertension
refers to the acute changes in blood pressure that occur
in the laboratory in response to mental challenge tasks.
Participants report that they find such tasks stressful, so the
blood pressure responses to such tasks are then defined as
a stress response. The mechanism of how such responses
lead to essential hypertension is difficult to establish,
although such responses do relate to the incidence of
later hypertension [64], and, as noted above, brain medi-
ation of such individual differences in responsivity seems
established [16, 17, 65]. Reviews support the prospective
relationship between heightened blood pressure response
to such laboratory challenges and subsequent hypertension
[15, 66]. This relationship has not been clearly shown to be
mediated by psychological factors although there is a report
of defensiveness contributing to the relationship between
blood pressure reactivity to laboratory stress and subsequent
high blood pressure [67]. The psychophysiological pathways
between such acute pressure changes and the chronic disease
state have been discussed by Krantz and Manuck [68].
As they note, the prospective correlation of acute blood
pressure reactions and later hypertension might be seen as
mechanistic if the laboratory reactivity generalized to either
repetitive reactions in daily life or tonic increases during
daytime or sleep hours [69, 70]. Strong evidence for such
relationships has not been found, however, [64] although
concepts of sustained reaction to acute events have been
proposed to interact with other factors in the etiology of
hypertension [71]. A promising, but not yet completely
established, link would be between hypertension and delayed
recovery of cardiovascular responses after an acute stressor as
possibly related to continuing intrusive thoughts relevant to
the stress, that is, rumination [72]. In short, stress defined
as a cardiovascular reaction can be related to hypertension,
but this defines stress in a circular fashion so our knowledge
of psychological factors, more commonly thought to involve
stress, is minimally advanced.
8. Pain and Hypertension
Although stress results in discomfort, the term is not usually
applied to the acute reaction to a noxious stimulus, pain.
Nonetheless, pain can be seen as a negative affect and pain
has been well studied as a function of blood pressure.
Pain perception is importantly related to blood pressure.
France [73] reviewed the large body of evidence relating
diminished pain sensitivity in animals and humans to high
blood pressure. He also addressed the question of whether
hypertension induces a reduction in pain sensitivity or if pain
sensitivity changes precede the development of hypertension.
Earlier, in a well-known paper, Dworkin et al. argued
that acute blood pressure increases reduced pain and thus
hypertension was acquired through instrumental learning
reinforced by this reduction in pain sensitivity [74, 75]. Their
model suggested that the baroreceptors in the carotid sinus
and aortic arch responded to transiently increased pressure
through transmission to the nucleus tractus solitarius, which
then had a damping effect both on pain perception and blood
pressure, see discussion of baroreceptor function in Berntson
et al. [76]. The association of a reduction in pain contingent
on an increase in blood pressure was the mechanism posited
to lead to hypertension. This model has mixed empirical
support and France [73] sought more general support
for the hypothesis that pain hyposensitivity precedes the
development of hypertension. This is supported by work in
animal models of hypertension; at risk animals tested prior
to the development of hypertension showing greater pain
hyposensitivity relative to animals not at risk. Studies of
humans at risk for hypertension due to family history and/or
heightened resting blood pressure also have been observed
to show a pain hyposensitivity. Finally, hypertension has
been related to reduced pain reports during induction of
baroreceptor reflexes. Based on this review, France [73]
speculated that pathophysiology of the paraventricular area
of the hypothalamus may be the mechanism for the reduced
pain sensitivity. Functioning of this area is thought to act on
pain through action of the baroreceptor reflex and its impact
on enkephalins, through heightened opioid stimulation, or
heightened activation of descending pathways inhibiting
pain. Although exceptions exist, the opioid changes related to
heightened blood pressure are the best known among these
supposed pathways [77–79]. Recent work on visceral and
somatic afferents, however, demonstrate surprisingly sus-
tained effects on blood pressure of small fiber stimulation—
effects mediated by long loop connections with the arcuate
nucleus of the hypothalamus (known to regulate endogenous
opioids) and with connections to neural areas known to exert
sympathetic nervous system influences on blood pressure
(i.e., rostral ventrolateral medulla) [80].
The relevance of this relationship between blood pressure
and pain perception is increased by recent studies on both
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brain imaging and the perception of emotion. Recent brain
imaging studies have examined the “pain” of social exclusion
and observed a striking overlap between brain regions
responsive to this and to physical pain [81, 82]. Such
findings support observations suggesting that blood pressure
regulation may be more generally related to affect, for
example, [83]. Relatedly, hints of an empirical relationship
between underreporting of affect/wellbeing and the relative
insensitivity to pain often observed among hypertensives
were also found by Nyklı´cˇek et al. [84].
9. Personality and Hypertension
The examination of “affective response” as related to stress
renders another review relevant; one relating hypertension
to psychological factors closer to personality in most cases
[85]. This review relates to the long history of cross-sectional
studies claiming to reveal a “hypertensive personality” (see
[27, 86, 87]), but chose to examine only prospective,
longitudinal studies excluding the possibility of an influence
of “hypertension awareness” andmore reasonably raising the
possibility that the psychological factor have a causative role.
Fifteen qualifying studies were found. The majority of these
examined negative affect (anger, hostility, defensiveness),
but depression, neuroticism, and psychopathology were also
represented. Among these studies, the majority was observed
to show a relationship, but the strength of the overall
relationship was low—corresponding to an r of.08. The
Sparrenberger review [63] comments that some subsequent
studies after the date of this review specifically examining
depression have not observed a relationship.
10. Psychological Processes and Hypertension
Although physiological reactions, recovery, and pain sensi-
tivity could mold personality and behavior, it seems more
likely that some aspect of personality might lead to consis-
tent interactions with the environment creating a risk for
hypertension. Such a personality feature might relate directly
to hypertensive risk or might act through cardiovascular
reactivity. (To date, however, a personality mediator for
blood pressure reactivity results has not been evident.) We
assume that this aspect of personality might contribute to
the present, but small relationships observed between stress
broadly conceived (as in the reviews above) and high blood
pressure. Based on our brain imaging results and the close
relationship between stress and affect, in the remainder of the
paper we will focus on current developments relating to the
question of whether a particular aspect of affect perception
and expression may be important in the etiology or early
stage of essential hypertension.
As noted earlier, early psychosomatic theories propose
a “hypertensive personality” that contributes to the devel-
opment of hypertension [1, 86–89], with persons at risk
for hypertension showing increased emotionality in everyday
situations [86, 87]. Other work suggested a blunted percep-
tion of negative events that might be yet more specific
than a personality type [90]. In the late 1970s Weiner [27]
reviewed this literature as suggesting a relatively socially
withdrawn personality that tended to be avoidant, but
that could be hostile. Subsequent literature focused on
the negative affect aspect. As noted above, a review of
studies prospectively relating psychological factors to the
development of hypertension did observe a small, but quan-
titatively supported relationship between measures of neg-
ative affect and hypertension development [85]. This rela-
tionship showed little specificity, however, as the measures
showing predictivity included anger-in, trait anger, anger-
out, anxiety, depression, anger-control, defensiveness, hope-
lessness, neuroticism, hostility and psychopathology.
11. Affectivity and Hypertension
There is a large body of literature connecting affect and hy-
pertension [27, 91, 92]. The concept of a “hypertensive
personality” origin of hypertension failed to achieve solid
support and research moved toward the belief that hyper-
tension and affective changes result from a common eti-
ology related to affect. The literature continued to relate
elevated blood pressure and essential hypertension with
lower affect expression, more negative affectivity, and defen-
siveness (for a comprehensive review that goes beyond that
possible here, see Jorgensen et al. 1996 [91]). Of note is
a review by [92] explicitly examining whether high neg-
ative affect (anger ex-perience) combined with inhibited
anger expression, that is, one version of the “hypertensive
personality”, was related to blood pressure. They failed to
find this relationship but did show a small quantitative rela-
tionship between experience of negative affect and blood
pressure—anger expression was not consistently related to
blood pressure [92]. Of interest though, they note that
the two scales most strongly relating negative affect/anger
experience to blood pressure assess both these feelings as well
as a reluctance to express such feelings.
The reluctance to express or even recognize affect has
been examined separately as a correlate of blood pressure.
Research on alexithymia, the inability to describe one’s
emotions, and hypertension has shown a positive relation-
ship. A number of studies using shortened versions of the
Toronto Alexithymia Scale (TAS) have found higher scores
on the TAS-20 or TAS-26 to be correlated with higher
blood pressures [93–96]. None of these studies have however
been able to move beyond the observed relationship to an
explanation of how hypertension leads to alexithymia or vice
versa. Furthermore, there is some disagreement about the
general relationship of alexithymia and hypertension [97, 98]
as well as concern that only particular aspects of alexithymia
may relate to heightened blood pressure [99]. Alexithymia
may be considered to reflect an inability to verbalize one’s
own emotions, but it might also reflect a general impairment
in the ability to recognize emotion. Lane et al. [100], for
example, found that two alexithymia measures, the Toronto
Alexithymia Scale and the Levels of Emotional Awareness,
both correlate with the Perception of Affect test, which
is designed to assess accuracy of verbal, non-verbal, and
mixed (verbal and nonverbal) emotion recognition. This
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relationship potentially links alexithymia to the literature on
decreased emotion recognition in hypertensives.
Blunted perception of negative affect as well as blunted
expression of affect once established has been suggested to
help those unsuccessful at interpersonal conflict to avoid
these situations resulting in a “profile of submissiveness,
conflict avoidance, and low levels of anger experience and
expression” [91]. A review by Jorgensen et al. focused on
studies looking at measures of affect expression, negative
affectivity, defensiveness (characterized by denial, repressive
coping, and damping of affective function), or a combination
of these in conjunction with measures of blood pressure
[91]. The resulting meta-analysis of 83 studies found that
individuals with higher blood pressure tended to have
lower affect expression but higher negative affectivity and
defensiveness than those with lower BP [91]. Additionally,
awareness of hypertensive status was a significant predictor
of study outcomes for both affect expression and negative
affectivity [91]. Studies were not available to test whether
awareness of hypertensive status influenced defensiveness. Of
note, whether they were aware or unaware of their blood
pressure levels, participants with high blood pressure were
lower on affect expression than participants with lower blood
pressure levels. Ultimately the analysis found defensiveness
to be the most robust predictor of high blood pressure [91].
The authors speculated that defensiveness may be linked to
the pain/opiod system: “(This association is) consistent with
the involvement of central opioid-peptide mechanisms in
the covariation of essential hypertension with defensiveness”
[91, p. 311].
Affect might not be the central concept–an alternative
perspective posits that hypertension induced changes in
cognitive processing (resulting in deficits in perception,
processing and recall of information) impairs affective
responses to demanding interpersonal interactions [101].
Cognitive deficits have, however, proven to be relatively
subtle and not present in low level processes such as
perception, speed of processing, or even long-term memory
[9, 60]. Mild deficits or blunted recognition and expression
of emotion might, however, lead to a history of unsuccessful
interpersonal interactions and through this to low self-
efficacy and avoidance behavior [102, 103].
12. Affect and Pain
Other research has focused on affect as a mediator of
pain perception in hypertension. An understanding that the
perception of pain is not simply a physical response led
researchers to explore the connection between hypoalgesia,
affect, and hypertension. Fillingim and colleagues suggested
that the effect of elevated blood pressure on pain is the
result of reduced affective response rather than reduced pain
sensitivity [104]. This relates to the surprising and reasonably
consistent finding that negative events and symptoms are
reported as lower among those with higher blood pressure,
but only among those not diagnosed with hypertension [61,
84, 105]. This relationship does not seem to be necessarily
related to negative affect/anxiety/defensiveness [105], but
as noted above may be related to pain perception [105].
Associating possible underlying mechanisms, Wilkinson and
France speculated that it is possible that changes in sensory,
affective, and cognitive processing of noxious stimuli may
influence hypoalgesia in hypertensives or those who are at
risk for hypertension [106]. They looked at the activation
of baroreflexes in conjunction with response to positive,
negative and neutral affective stimuli. Though no connection
was found between baroreflex stimulation and affective
measures, an interaction between parental history of hyper-
tension andmood showed reduced emotional valence ratings
for both positive and negative images, but not for neutral
images for subjects who had a positive parental hypertension
history versus those whose parents did not have hypertension
[106]. For ratings of arousal, those who have a positive
parental history of hypertension reported less arousal to
both positive and negative stimuli and higher arousal to
neutral stimuli when compared to participants who had
normotensive parents [106]. Although this study did not find
support for the role of baroreflex stimulation in affective
responding among individuals at risk for hypertension, the
discovery of dampened emotional responses to both positive
and negative stimuli in conjunction with similarly dampened
autonomic and involuntary measures of response (i.e., skin
conductance and EMG) for participants with a parental
history of hypertension reinforce the belief that a common
underlying mechanism contributes to the changes in affect,
blood pressure, and other autonomic responses [106].
13. Positive Affect
It is important to keep in mind that affective response
is multidimensional (e.g., valence positive-to-negative state
and arousal high-to-low energy state) as a result, expansion
of research into positive affectivity seemed the obvious
next step. Pury et al. proposed that emotional responses
of persons with high blood pressure to a broader range
of stimuli (things other than stress and physical pain) can
happen in 3 different ways: (1) lessened response to negative
stimuli with no change in response to positive stimuli, (2)
more positive responses to both positive and negative stimuli,
or (3) “dampened emotional responses” to both positive and
negative stimuli [107]. In their study Pury and colleagues
took resting blood pressures of 65 normotensive young
adults and then asked them to rate a series of photographs
on valence and arousal [107]. Systolic BP was found to be
associated with more neutral ratings for all of the photos, as
well as for the positive photos and for the negative photos
[107]. These findings show a dampened emotional response
to visual stimuli for persons with a higher resting SBP
causing Pury and colleagues to suggest that “prior research
on the relationship between blood pressure and subjective
ratings of negative stimuli (pain, psychosocial stress) may be
reflecting a general tendency toward reduced responsiveness
to emotionally provocative stimuli in general” [107, p. 585].
A more recent study by McCubbin et al. [108] found
that zero order correlations show an inverse relationship
between the Perception of Affect task scores and both systolic
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Table 1: Diagrammatic illustration of integrated study of the natural history of hypertension.
Stage of Disease Physiology Affective Cognitive
Normotensive/youth
(genetic/familial risk)
All normal possible hyper-reactivity to
lab stress, Mild elevation in SBP Opioid
dysregulation
Anger? Reduced pain sensitivity
Subtle spatial attention, short
term memory deficit
Borderline/Pre-hypertensive
BP >119/79 <140/90 with predominance
of elevated DBP, sympathetic activa-
tion High cardiac output Baroreceptor
adjustment; hyper reactivity to lab stress
Interpersonal difficulty Pain
insensitivity Less awareness
negative affect, positive affect?
Early Hypertension
(40–60yrs)
BP >140/90 High TPR Salt/diet sensitive
Renin/angiotensin Aldosterone Sympa-
thetic Structural/function brain changes
Hyperreactivity
Above with transition to greater
negative affect with inhibition
of the expression of intense
angry cognitive and emotive
reactions
Mild deficits executive atten-
tion, working memory
Late Hypertension
(60+ yrs)
Same BP or isolated systolic hyperten-
sion? maintenance of altered regulatory
system
Continued high negative affect
and expression of negative
affect?; awareness of BP status
may invert relationship
Deficits not as clear relative
to age matched; Related to
Alzheimer’s Disease
and diastolic blood pressure in a predominantly African
American sample. This finding further supports the theory
of emotional dampening in persons with elevated blood
pressure [108]. In summary the current literature seems
to point at an evolving relationship between hypertension
and affectivity. With those likely to develop hypertension
exhibiting intense emotionality specifically in relation to the
expression of anger and developing into blunted perception
and expression of both positive and negative emotion [86,
87, 91, 107]. The evolution in the relationship between
hypertension and affect further supports the idea for a
common etiology, however there is much yet to be explored.
14. Concluding Remarks
Continued exploration into both positive and negative
aspects of emotionality will be important in understand-
ing the connection between hypertension and affectivity.
Additionally, understanding this psychosomatic relationship
requires careful concurrent assessment of both physiology
and psychological function using valid and reliable measures.
As Suls et al. [92] note, earlier work has been characterized
by either careful psychological or physiological assessment
but rarely by care in both areas. Prospective studies of the
development of hypertension while monitoring affect and
cognition will add much to the existing literature. As the
relationship of blunted perception of affect (or of negative
events) continues to be explored it should be useful to relate
it to concepts of the development of hypertension. Weiner
[27] reviewed work suggesting that normal blood pressure
advanced to hypertension through a prehypertensive phase
that could take different forms: initial increase in cardiac
output, an increase in both heart rate or cardiac output, or
an increase in peripheral vascular resistance. Although work
has not refined these speculations greatly, the point is that
the hypertension likely results from a variety of mechanisms
and one of more of these may relate more strongly to the
perceptual sensitivity characterizing some individuals that
advance to hypertension. Table 1 is a rough table of what is
somewhat known about physiology, affect, and cognition at
different stages of hypertension. The table is incomplete, par-
ticularly in terms of the multiple physiological mechanisms
suspected to impact hypertension. Brain indices are included
but very little work has been done in this area. We have tried
to develop the case that brain indices as well as self-report
indices are pointing to a possible convergence that may
enlighten us on how exactly affect, its perception, regulation,
and expression may be related to the natural history of
hypertension. As research goes forward, assessment of both
continuous blood pressure as well as categorical measures
relating to medical definitions of the disease should be
included with attention to the issue of whether individuals
are aware or unaware of their hypertensive status. The
area would further benefit from the use of well-developed
scales of affect that can be compared across studies as well
as the use of any newly developed measures that capture
hypotheses about the tantalizing relationship between affect
and hypertension.
Notes. Progression of blood pressure with age derived
from Franklin and Mitchell [109], early neuropsychologi-
cal deficits [110, 111]. Physiological characterizations are
incomplete; borderline/prehypertensive based on Ko¨hler,
Fricke, Ritz, & Scherbaum et al. [112]. Alzheimer relation-
ship based on Wu et al. [113]. Dysregulation in multiple
systems may independently lead to hypertension and the
timing of such changes are largely unknown in humans.
Evidence for this can be readily deduced from the variety of
animal models that achieve hypertension via different routes
[114].
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